France

Big day for legal cannabis in France: ANSM endorses medical cannabis pilot and launch of cannabis Parliamentary Mission

Eveline Van Keymeulen

Today is a big day for legal cannabis in France.  Earlier this morning, the French National Agency for Medicines and Health Products Safety (ANSM) endorsed the medical cannabis pilot programme per the recommendations of the French specialised committee on cannabis (CSST) which were published on 28 June (see our earlier blog post: “French cannabis committee Read More

Big data in healthcare: key recommendations of the French National Ethical Consultative Committee for Life Sciences

Laurie-Anne Ancenys

On 29 May 2019, the French National Ethical Consultative Committee for Life Sciences and Health (CCNE) delivered its Opinion (n°130) on ethical issues in connection with big data in the health sector (the Opinion). The Opinion aims at identifying the ethical challenges raised by the exploitation of large set of data in healthcare and provide Read More

French cannabis committee unveils recommendations for medical cannabis pilot programme in France

Eveline Van Keymeulen

Yesterday, the French specialised committee on cannabis (CSST), which was established in mid-2018, held its last meeting and presented its final recommendations for the implementation of a medical cannabis pilot programme to the French National Agency for Medicines and Health Products Safety (ANSM).  Last week, on 19 June 2019, the CSST had already published the Read More

The cannabis market: helping investors navigate the UK regulatory regime

Matthew Townsend

Last year the global legal cannabis market was estimated to be worth USD12 billion but it is tipped to rise to over USD166 billion by 2025. Liberalisation of the legal framework for cannabis is a significant driver for this growth. Since 1 November 2018, the UK has joined the ranks of over 30 countries legalising Read More

Medical cannabis in France: Latest state of play

Eveline Van Keymeulen

Following the penultimate meeting of the specialised committee on cannabis (CSST) established by the French National Agency of Medicine and Health Products Safety (ANSM) (see our previous blog posts “French ANSM temporary scientific committee pursues activities on modalities of medical cannabis availability” and “French ANSM recommends medical use of cannabis under certain conditions“), the French Senate Read More